2-190208668-A-ATTTT
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_014362.4(HIBCH):c.1045+211_1045+212insAAAA variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.017 ( 83 hom., cov: 0)
Exomes 𝑓: 0.0032 ( 2 hom. )
Consequence
HIBCH
NM_014362.4 intron
NM_014362.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.641
Genes affected
HIBCH (HGNC:4908): (3-hydroxyisobutyryl-CoA hydrolase) This gene encodes the enzyme responsible for hydrolysis of both HIBYL-CoA and beta-hydroxypropionyl-CoA. Mutations in this gene have been associated with 3-hyroxyisobutyryl-CoA hydrolase deficiency. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 2-190208668-A-ATTTT is Benign according to our data. Variant chr2-190208668-A-ATTTT is described in ClinVar as [Benign]. Clinvar id is 1279360.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0575 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HIBCH | NM_014362.4 | c.1045+211_1045+212insAAAA | intron_variant | ENST00000359678.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HIBCH | ENST00000359678.10 | c.1045+211_1045+212insAAAA | intron_variant | 1 | NM_014362.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0172 AC: 2343AN: 136296Hom.: 82 Cov.: 0
GnomAD3 genomes
AF:
AC:
2343
AN:
136296
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00323 AC: 1055AN: 326654Hom.: 2 Cov.: 0 AF XY: 0.00334 AC XY: 584AN XY: 174878
GnomAD4 exome
AF:
AC:
1055
AN:
326654
Hom.:
Cov.:
0
AF XY:
AC XY:
584
AN XY:
174878
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0172 AC: 2348AN: 136304Hom.: 83 Cov.: 0 AF XY: 0.0173 AC XY: 1139AN XY: 65786
GnomAD4 genome
AF:
AC:
2348
AN:
136304
Hom.:
Cov.:
0
AF XY:
AC XY:
1139
AN XY:
65786
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 18, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at